Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
17-alpha-hydroxylase, encoded by the CYP17A1 gene, is an enzyme crucial for steroid hormone biosynthesis. It catalyzes two key reactions: 17α-hydroxylation of pregnenolone and progesterone, and cleavage of the C17-C20 bond to produce DHEA. Deficiencies lead to congenital adrenal hyperplasia, characterized by impaired glucocorticoid and sex hormone production, resulting in hypertension, hypokalemia, and abnormal sexual development.
Inhibition of 17-alpha-hydroxylase activity, leading to reduced glucocorticoid and sex steroid synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 17-alpha-hydroxylase.